Indoleamine 2,3-dioxygenase in tumor induced tolerance

被引：19
作者：
Liu Xiao-qian [1 ]
Wang Xin [1 ]
机构：
[1] Shandong Univ, Dept Hematol, Prov Hosp, Jinan 250021, Shandong, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2009年 / 122卷 / 24期
关键词：
indoleamine 2,3-dioxygenase; immune tolerance; dendritic cells; regulatory T cells; 1-methyl-tryptophan; REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; DRAINING LYMPH-NODES; TRYPTOPHAN CATABOLISM; BACTERIAL LIPOPOLYSACCHARIDE; INCREASED POPULATIONS; PERIPHERAL-BLOOD; IDO; INHIBITION; EXPRESSION;
D O I：
10.3760/cma.j.issn.0366-6999.2009.24.030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To review the recent studies about the role of indoleamine 2,3-dioxygenase (IDO) in tumor induced tolerance. Data sources Published articles (1978-2009) on IDO and tumor induced tolerance were selected from Medline. Study selection Articles selected were relevant to development of IDO in tumor induced tolerance. Of all originally identified articles, 50 specially addressed the stated purpose. Results Recent work has revealed IDO at high levels in tumors and in tumor-draining lymph nodes and a close relationship between IDO activity and the regulatory T cells. Conclusion Up-regulation of IDO is proven to be a mechanism of acquired tolerance in tumors, in which the closely coupled positive feedback system between IDO and regulatory T cells may be considered to play an important role. Chin Med J 2009,122(24):3072-3077
引用
收藏
页码：3072 / 3077
页数：6
相关论文
共 50 条
[31]   Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase [J].
Munn, DH ;
Sharma, MD ;
Lee, JR ;
Jhaver, KG ;
Johnson, TS ;
Keskin, DB ;
Marshall, B ;
Chandler, P ;
Antonia, SJ ;
Burgess, R ;
Slingluff, CL ;
Mellor, AL .
SCIENCE, 2002, 297 (5588) :1867-1870
[32]   GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase [J].
Munn, DH ;
Sharma, MD ;
Baban, B ;
Harding, HP ;
Zhang, YH ;
Ron, D ;
Mellor, AL .
IMMUNITY, 2005, 22 (05) :633-642
[33]   Prevention of allogeneic fetal rejection by tryptophan catabolism [J].
Munn, DH ;
Zhou, M ;
Attwood, JT ;
Bondarev, I ;
Conway, SJ ;
Marshall, B ;
Brown, C ;
Mellor, AL .
SCIENCE, 1998, 281 (5380) :1191-1193
[34]   Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes [J].
Munn, DH ;
Sharma, MD ;
Hou, D ;
Baban, B ;
Lee, JR ;
Antonia, SJ ;
Messina, JL ;
Chandler, P ;
Koni, PA ;
Mellor, AL .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :280-290
[35]   IDO and tolerance to tumors [J].
Munn, DH ;
Mellor, AL .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (01) :15-18
[36]   Tryptophan depletion and HIV infection: a metabolic link to pathogenesis [J].
Murray, MF .
LANCET INFECTIOUS DISEASES, 2003, 3 (10) :644-652
[37]   Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells [J].
Okamoto, A ;
Nikaido, T ;
Ochiai, K ;
Takakura, S ;
Saito, M ;
Aoki, Y ;
Ishii, N ;
Yanaihara, N ;
Yamada, K ;
Takikawa, O ;
Kawaguchi, R ;
Isonishi, S ;
Tanaka, T ;
Urashima, M .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :6030-6039
[38]   Toward the identification of a tolerogenic signature in IDO-competent dendritic cells [J].
Orabona, C ;
Puccetti, P ;
Vacca, C ;
Bicciato, S ;
Luchini, A ;
Fallarino, F ;
Bianchi, R ;
Velardi, E ;
Perruccio, K ;
Velardi, A ;
Bronte, V ;
Fioretti, MC ;
Grohmann, U .
BLOOD, 2006, 107 (07) :2846-2854
[39]   Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma [J].
Ormandy, LA ;
Hillemann, T ;
Wedemeyer, H ;
Manns, MP ;
Greten, TF ;
Korangy, F .
CANCER RESEARCH, 2005, 65 (06) :2457-2464
[40]   The Immunoregulatory Enzyme IDO Paradoxically Drives B Cell-Mediated Autoimmunity [J].
Scott, Grant N. ;
DuHadaway, James ;
Pigott, Elizabeth ;
Ridge, Natalie ;
Prendergast, George C. ;
Muller, Alexander J. ;
Mandik-Nayak, Laura .
JOURNAL OF IMMUNOLOGY, 2009, 182 (12) :7509-7517
12345